James Comer says Congress should weigh prediction market ban for federal staff
The House Oversight chairman released a staff memo recommending lawmakers consider barring government officials from trading prediction markets, citing insider trading concerns.
Why it matters: The memo signals that Congress may legislate on prediction markets, a sector already facing CFTC enforcement and scrutiny from incoming Senate Banking chair Elizabeth Warren.
Key points
- The memo follows an investigation that gathered nearly 1,700 pages of documents and five bipartisan staff briefings with prediction market platforms.
- Polymarket, which launched Chainalysis-built surveillance software called PolyGraph, and Kalshi were credited for flagging suspicious activity.
The House Oversight Committee is weighing whether to bar government officials from prediction markets, after a staff memo raised concerns about insiders trading on nonpublic information. Chairman James Comer released the memorandum on 13 November, setting out the findings of an investigation into insider trading by officials, military personnel and security-clearance holders on platforms such as Kalshi and Polymarket.
The probe collected nearly 1,700 pages of documents and held five bipartisan staff briefings with prediction market platforms on how they spot and report suspicious activity. Comer framed the issue around public trust, saying Americans are rightly worried about corruption and that lawmakers have a duty to stop officials profiting from information they hold privately.
The memo noted that existing law already reaches these markets.
What to watch: Congress is to consider the memo's recommended restrictions on federal personnel trading prediction markets; no vote or deadline is given.
Live updates on NewsFeeds:RegulationDesk editor: Keshav Aggarwal (accountable for this page; this summary was not edited by hand)
How this was produced: an AI model wrote this summary of Decrypt’s report, which we credit and link above. Read our Editorial and AI policy. Spotted a mistake? See Corrections.
Not investment advice. Read the risk disclaimer.